Melanie Littlewood is the Senior Director of Value and Access at Insulet International, where she leads market access and reimbursement strategies for diabetes technologies. Her career includes roles at Eli Lilly and Abbott, with a focus on medical devices, immunology, and diabetes care. She is a graduate of Glasgow Caledonian University and a PRINCE2 Practitioner.
Melanie is a passionate advocate for translating clinical and economic evidence into policy to ensure patients can access innovative treatments. She frequently contributes to research and emphasizes that integrity and a strong moral compass are foundational to her leadership style, driving her decisions and actions.
She was a co-author of several recent studies on the efficiency and quality-of-life benefits of tubeless insulin pump technology.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.